Home | Welcome to Contract Pharma   
Last Updated Saturday, September 20 2014
Print

SNBL USA Names European BD Director



Published September 10, 2013
Related Searches: Development Toxicology Preclinical
Janet Kelly, MSc, has been appointed director of business development for the European region at SNBL USA. Ms. Kelly will be responsible for driving growth of the European business, including fostering relationships with new and current customers.
 
Ms. Kelly joins the company from CJS Scientific, Ltd., where she served as director and consultant to the pharmaceutical and agrochemical industries in the fields of nonclinical development, toxicology, translational medicine and dossier preparation. Prior to CJS she held several positions at Covance, including director of operations at Covance R&D (Shanghai, China), associate director of business development, head of operations and head of toxicology study direction.
 
“With more than 26 years of industry experience, Janet has held a number of key posts with progressively responsible roles in study direction, business development and operations,” said Mark Crane, SNBL USA vice president of business development. “Her preclinical market understanding, experiences and direct knowledge of the rapidly changing European market dynamics will be of great value to SNBL USA and all its customers. I am excited to have Janet on our team.”


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On